Mark Weinreb, CEO and Chairman of the Board at BioRestorative Therapies, Inc. (BRTX), bought 22,000 shares at $0.24 ($6K) on 2019-09-06, disclosed to the SEC on 2019-09-06.
Open-market purchase of $6k BRTX by CEO and Chairman of the Board. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.27 | 10,000 | $3K | 48.7% |
| 2 | $0.23 | 4,000 | $920 | 16.6% |
| 3 | $0.24 | 2,500 | $600 | 10.8% |
| 4 | $0.24 | 5,500 | $1K | 23.8% |
| Total | $0.25 avg | 22,000 | $6K | 100% |
| Filing → |